Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications
Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention
Cognitive deficits and cortical volume loss in COVID-19-related hyposmia
Cognitive domains affected post-COVID-19: a systematic review and meta-analysis
Comorbidities and neurosurgical interventions in a cohort with connective tissue disorders
Diagnosis and management of status epilepticus: improving the status quo
Epilepsies in children, young people and adults (updated NICE guideline NG217)
The European Academy of Neurology NeuroCOVID-19 Task Force: a lesson for the future
Functional connectivity and metabolic brain alterations in sleepwalkers
The influence of menopause on multiple sclerosis
Mitochondrial DNA (mtDNA) as fluid biomarker in neurodegenerative disorders: a systematic review
Neurocognitive performance in functional neurological disorder
Perspectives on the diagnosis and management of functional cognitive disorder
Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis
Spontaneous intracranial hypotension — neurological symptoms, diagnosis, and outcome
Unique considerations in the assessment and management of traumatic brain injury in older adults
Annals of Clinical and Translational Neurology (Oct-Nov); European Journal of Neurology (Jan-Feb); Frontiers in Neurology (Jan); Lancet Neurology, The (Jan-Feb)
Antiseizure medications and cardiovascular events in older people with epilepsy
Antiseizure medication use and outcomes after suspected or confirmed acute symptomatic seizures
Azathioprine for people with multiple sclerosis (new Cochrane intervention review)
Beyond seizure freedom: reduction in anti-seizure medication after epilepsy surgery
Clinical trials for Lennox–Gastaut syndrome: challenges and priorities
Comorbidity and disease activity in multiple sclerosis
Dysphagia assessment in patients with multiple sclerosis – an additional piece to disability burden
Hearing loss, incident Parkinson disease, and treatment with hearing aids
Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment
Neurotoxicity of per- and polyfluoroalkyl substances: evidence and future directions
Perceived chronic traumatic encephalopathy and suicidality in former professional football players
Rituximab in secondary progressive multiple sclerosis: a meta-analysis
Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic
Annals of Clinical and Translational Neurology (Oct-Nov); Cochrane Library (Nov-Dec); Epilepsy Research (Dec); JAMA Neurology (Nov-Dec); Journal of Hazardous Materials (Dec); Lancet Neurology (Dec)
Altered brain perfusion and oxygen levels relate to sleepiness and attention in post-COVID syndrome
Assistive technologies, including orthotic devices, for the management of contractures in adults after a stroke (new Cochrane intervention review)
CNS disease associated with enhanced type I interferon signalling
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis
Differential diagnosis of suspected multiple sclerosis: global health considerations
Endovascular stroke thrombectomy for patients with large ischemic core: a review
Exergaming for dementia and mild cognitive impairment (new Cochrane intervention review)
Frailty for neurologists: perspectives on how frailty influences care planning
The impact of diagnosis delay on European patients with generalised myasthenia gravis
Itching frequency and neuroanatomic correlates in frontotemporal lobar degeneration
MRI evidence of gray matter loss in COVID-19 patients with cognitive and olfactory disorders
The neural substrates of social cognition deficits in newly diagnosed multiple sclerosis patients
New onset status epilepticus and its long-term outcome: a cohort study
Objective and subjective cognitive outcomes one year after COVID-19
Prevalence of epilepsy in people of sexual and gender minoritized groups
Psychosis and schizophrenia among patients with epilepsy: a systematic review and meta-analysis
Risk of perinatal and maternal morbidity and mortality among pregnant women with epilepsy
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population
Annals of Clinical and Translational Neurology (Jul-Sep); Cochrane Library (Sep-Oct); Epilepsy Research (Oct-Nov); JAMA Neurology (Sep-Oct); Lancet Neurology (Oct-Nov); NPJ Parkinson’s Disease (Aug)
The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.